Key figures
-
21.0
billion euro net sales in 2023
-
5.9
billion euro EBITDA pre in 2023
-
63000
employees around the world
Latest News
View all news-
Press Releases
Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
Memorandum of Understanding signed to drive digital transformation through strategic projects across all three business sectors
2024/09/16
-
Press Releases
Merck KGaA, Darmstadt, Germany Unveils New MAVENCLAD® Four-Year ...
The company today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine) tablets in relapsing multiple sclerosis.
2024/09/12
-
Press Releases
MilliporeSigma Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing
MilliporeSigma launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs).
2024/09/10
Stay up-to-date
You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe
-
Media Contacts
Get in touch!for journalists, bloggers or multipliers.
-
Media downloads
Browse and download high-quality images and video footage.Access gallery -
Press Kits
Collected Topicswith all the facts and relevant background information on particularly important topics.
This might also interest you
-
Strategy & Values
Learn moreWe believe in science and technology as a force for good.
-
Stories
Learn moreLearn more about our company and the people behind it.
-
Sustainability
Learn moreWe want to create long-term added value for society.
-
Our sites
Learn moreLearn where you can find us around the world.
EVEN MORE INFORMATION
Upcoming Events
View All EventsOur Q3 2024 results will be published on November 14, 2024, at 7 a.m. (CET). Our conference call for the media will take place at 9:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).